Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In the majority of patients, a posteroanterior and lateral chest x-ray will confirm and localize an effusion. Ultrasound, lateral decubitus films and computed tomography scanning are more sensitive in diagnosing and localizing small effusions.
Pleural fluid analysis is the principal method of determining the underlying cause of an effusion.
Ultrasound-guided thoracocentesis is the recommended method for diagnostic or therapeutic fluid drainage.
Treatment is dependent on the underlying disease. Large pleural effusions with cardiorespiratory compromise should be aspirated to provide symptomatic relief.
Transudates generally respond to treatment of the underlying condition. Exudates usually require further investigative procedures and specific treatments.
A pleural effusion is an accumulation of fluid in the pleural space caused by a disruption of the homoeostatic forces that control normal flow. Massive pleural effusions may produce significant cardiorespiratory compromise requiring urgent attention in the emergency department. However, many are asymptomatic or produce minimal disturbance. In this latter group, the role of emergency department care is assessment to ascertain the aetiology of the effusion, as this dictates the most appropriate treatment. Information regarding the likely cause can be obtained by a thorough history and physical examination. Important adjuvant investigations include chest x-ray (CXR), ultrasound, examination of pleural fluid and biopsies obtained during thoracocentesis. Bronchoscopy and thoracoscopy have a role to play in the small group of patients in whom the mentioned procedures fail to establish a cause; however, their use is beyond the scope of initial emergency department assessment and stabilization.
The pleural cavity is normally a small space bordered by the visceral and parietal pleura, both of which are composed of mesothelial lining cells. In normal conditions it contains approximately 0.25 mL/kg of low-protein liquid. The pleura act as semipermeable membranes and fluid movement is determined principally by capillary pressure, plasma oncotic pressure and capillary permeability, governed by the Starling law. The parietal pleura appear to be the more important surface for pleural liquid turnover in the normal physiological state. Current evidence suggests that most pleural fluid drainage occurs via pleuro-lymphatic communications or stomas, augmented by respiratory muscle action and intrinsic lymphatic vessel contractility. Overall absorptive capacity can exceed production by a factor of 10 to 20, allowing maintenance of pleural fluid volume in most cases. Pleural effusions occur due to one of the following:
Disturbances in the hydrostatic-osmotic pressure gradients, resulting in a transudate
Pleural inflammation with loss of semipermeable membrane function, resulting in a protein-rich exudate
Lymphatic obstruction (usually producing a transudate)
Transudates are ultrafiltrates of plasma and arise as a result of relatively few conditions. Exudates are produced by a wider variety of inflammatory conditions and often require more extensive investigation.
Box 6.7.1 lists the causes of transudative and exudative pleural effusions. The commonest causes are congestive cardiac failure, pneumonia, malignancy and pulmonary embolus.
Congestive cardiac failure
Cirrhosis
Nephrotic syndrome
Peritoneal dialysis
Hypoalbuminaemia
Urinothorax
Atelectasis
Constrictive pericarditis
Superior vena caval obstruction
Cerebrospinal fluid leaks (trauma, surgery, Ventriculoperitoneal (VP) shunts)
Glycinothorax
Malignancy
Pulmonary embolism
Sarcoidosis
Hypothyroidism
Infectious
Bacterial pneumonia
Tuberculosis
Parasites
Fungal disease
Atypical pneumonia
Nocardia, actinomyces
Subphrenic abscess
Hepatic abscess
Splenic abscess
Hepatitis
Spontaneous oesophageal rupture
Drug-induced (amiodarone, phenytoin, nitrofurantoin, β-blockers, dantrolene sodium, methysergide maleate, procarbazine HCl, methotrexate, medications causing drug-induced lupus syndrome: procainamide HCl, hydralazine HCl, quinidine)
Oesophageal perforation
Oesophageal sclerotherapy
Central venous catheter migration
Enteral feeding
Post–coronary artery bypass graft
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here